HNL — Dr Hoenle AG Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapNeutral

Annual cashflow statement for Dr Hoenle AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7.85	-0.608	-11.5	-11	-12.2
Depreciation
Non-Cash Items	0.809	4.02	10.8	11.3	3.15
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-8.03	-15.8	-21.1	-7.16	1.39
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7.23	1.13	-7.41	3.14	5.53
Capital Expenditures	-30.2	-17.1	-4.31	-2.93	-2.09
Purchase of Fixed Assets
Other Investing Cash Flow Items	-0.543	-7.41	2.62	5.58	-0.278
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-30.7	-24.5	-1.69	2.65	-2.37
Financing Cash Flow Items	0.056	0	—	—	-0.123
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	43.3	1.25	3.73	-3.42	-4.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	19.6	-22.1	-4.94	2.19	-1.81